Duffy Sean P. 4/A

What Happened

• Sean P. Duffy, CEO of Omada Health (OMDA), exercised a total of 17,258 option shares and sold those same shares in same-day exercise-and-sale transactions on June 24–26, 2026. Exercises included 2,800 shares @ $5.82 (6/24), 300 @ $5.82 (6/25), 9,844 @ $5.82 (6/26) and 4,314 @ $8.28 (6/26). Total exercise cost reported: ~$111,054. The corresponding open-market sales were: 2,800 shares @ $19.01, 300 @ $19.00, 9,844 @ $19.61 (weighted avg), and 4,314 @ $20.90 (weighted avg), producing aggregate proceeds of about $342,116. The Form 4/A also shows corresponding derivative dispositions at $0 reflecting the options cancelled on exercise.

Key Details

• Transaction dates: June 24, 25 and 26, 2026; sale prices reported as weighted averages where multiple trades occurred.
• Shares sold: 17,258; aggregate sale proceeds ≈ $342,116. Aggregate cash paid to exercise ≈ $111,054.
• Filing status: This is an amended Form 4 (Form 4/A). The amendment restates the original 6/26/2026 filing to report exercises that were inadvertently omitted; the sales had been timely reported originally. (See footnote F1.)
• 10b5-1 plan: At least some transactions were executed pursuant to a 10b5-1 trading plan adopted March 13, 2026 (F2).
• Multiple-trade reporting: Some sales executed in multiple trades at slightly varying prices; reported amounts are weighted averages (F3, F4).
• Options/status: 100% of the shares subject to the option were fully vested and exercisable (F6). Some shares are held in family trusts; the reporting person disclaims beneficial ownership of those except to the extent of pecuniary interest (F5).

Context

• These were cashless, same-day exercise-and-sale transactions (exercise followed by immediate sale), a common way for insiders to monetize vested options; such transactions do not necessarily indicate a change in view of the company. The amendment corrects previously omitted exercise entries so the beneficial ownership totals were adjusted on the amended Form 4/A.